Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-746-1 | CAS number: 87-44-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2002 to 2003
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- A skin sensitiser is an agent that will lead to an allergic response in susceptible individuals following skin contact. Human experimental studies are not recommended to fulfil REACH Annex VII information requirements. However, all existing available information should be evaluated, including any available human data. The human patch test is a confirmatory test in the safety evaluation of skin sensitisers involving the repeat exposure of small patches of skin to the test item. Whilst the CLP regulation does not contain clear criteria for classification for skin sensitisation based on human data, the studies can substantiate no-effect levels and ensure that matrix effects are not making an unexpected contribution to sensitising potency.
Data source
Reference
- Reference Type:
- publication
- Title:
- Selected oxidized fragrance terpenes are common contact allergens
- Author:
- Matura M, Sköld M, Börje A, Andersen KE, Bruze M, Frosch P, Goossens A, Johansen JD, Svedman C, White IR, Karlberg AT
- Year:
- 2 005
- Bibliographic source:
- Contact Dermatitis, 52, 320–328
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- study with volunteers
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Inclusion/exclusion criteria: Patients with known and/or suspected fragrance allergy and patients with hand eczema without known adverse reactions to fragrances were included.
- Principle of test: Dermatitis patients were tested with the maximal non-irritant test item concentrations at the participating dermatology clinics of Copenhagen, Dortmund, Leuven, London, Malmö and Odense during 2002–2003. A questionnaire about clinical data (i.e. localisation of symptoms, history of atopy and occupation) was filled out before testing. An additional two step targeted study was performed in Odense and Leuven including patients with fragrance hypersensitivity without hand eczema, and patients with hand eczema but without adverse reaction to fragrances.
- Short description of test conditions: Patch test materials were applied in small (8 mm) Finn Chambers on Scanpor tape. Readings were taken twice, on days 2 and 4 (exceptionally on day 3) in Leuven, London and Dortmund, and on days 3 and 6/7 in the other
centres, and scored according to the ICDRG standard recommendations.
- Parameters analysed / observed: Positive / negative reactions - GLP compliance:
- no
Test material
- Reference substance name:
- Caryophyllene
- EC Number:
- 201-746-1
- EC Name:
- Caryophyllene
- Cas Number:
- 87-44-5
- Molecular formula:
- C15H24
- IUPAC Name:
- (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene
Constituent 1
Method
- Type of population:
- other: dermatitis patients
- Ethical approval:
- confirmed and informed consent free of coercion received
- Subjects:
- - Number of subjects exposed: 1151
- Demographic information: Participants undertook testing in Copenhagen, Dortmund, Leuven, London, Malmö and Odense - Clinical history:
- - History of allergy or casuistics for study subject or populations: The irritation test was performed with dermatitis patients. The targeted study was performed with patients with fragrance hypersensitivity without hand eczema, and patients with hand eczema but without adverse reaction to fragrances.
- Exposure history: The patients with fragrance allergy (n = 21) were partly recruited for retesting among previously tested individuals who had shown positive reactions to fragrance allergy markers and own perfumes, and partly chosen from consecutive dermatitis patients who had a certain history of adverse reactions to fragrances. In the two-step-targeted study, there were 66 patients with hand eczema and no history for adverse reaction to fragrances. - Controls:
- None reported
- Route of administration:
- dermal
- Details on study design:
- TYPE OF TEST(S) USED: patch test (epicutaneous test)
ADMINISTRATION
- Description of patch: Patch test materials were applied in small (8 mm) Finn Chambers on Scanpor tape (Epitest, Tuusula, Finland).
- Vehicle / solvent: Non-stabilised white petrolatum
- Concentrations: The irritation study and targeted test were performed with 3.0% (w/w) oxidation mixture of β-caryophyllene and 3.9% (w/w) caryophyllene oxide. Oxidized β-caryophyllene contained 25% β-caryophyllene and 35% caryophyllene oxide.
- Volume applied: 20 µL
- Testing/scoring schedule: Readings were taken twice, on days 2 and 4 (exceptionally on day 3) in Leuven, London and Dortmund, and on days 3 and 6/7 in the other centres.
- Other: To mimic the oxidation that takes place during handling and storage, β-caryophyllene was air exposed in an Erlenmeyer flask, covered with aluminium foil to prevent contamination, and stirred for 1 h, 4 times a day. An oxidised sample of β-caryophyllene (air-exposed for 10 weeks) was stored under nitrogen at –20°C until test preparations were made.
EXAMINATIONS
- Grading/Scoring system: ICDRG standard recommendations
- Statistical analysis: Chi-square test was used for the analysis of concomitant positive reactions.
Results and discussion
- Results of examinations:
- Testing with oxidation mixture of caryophyllene gave positive reactions in 8/1511 patients (0.5%), of whom 2 also reacted to caryophyllene oxide. In the two-step-targeted study, the oxidation mixture of caryophyllene gave 1 reaction.
Any other information on results incl. tables
Table 1. Positive patch test reactions to oxidized terpenes and oxidation fractions in 1511 consecutive dermatitis patients at 6 dermatological centres
Test item | Dortmund (n = 223) | Gentofte (n = 230) | Leuven (n = 200) | London (n = 302) | Malmö (n = 294) | Odense (n = 262) | Total (n = 1511) |
Oxidation mixture of caryophyllene 3.0% pet. | 2 (0.9%) | 0 | 1 (0.5%) | 2 (0.7%) | 0 | 3 (1.1%) | 8 (0.5%) |
Caryophyllene oxide 3.9% pet. | 1 (0.4%) | 0 | 0 | 0 | 0 | 1 (0.4%) | 2 (0.1%) |
Table 2. Questionable and positive patch test reactions to oxidized and non-oxidized terpenes, oxidation compounds and fractions in the targeted study of patients with hand eczema or fragrance hypersensitivity in Odense and Leuven
Test item | Concentration | Fragrance hypersensitivity patients (n = 21) | Hand eczema patients (n = 66) | ||
Questionable | Positive | Questionable | Positive | ||
Caryophyllene oxide | 3.9% | 2 | 0 | 1 | 0 |
Oxidation mixture of caryophyllene | 3% | 0 | 1 (++) | 0 | 0 |
Applicant's summary and conclusion
- Conclusions:
- About 0.5% of the patients (n = 1511) reacted to oxidised caryophyllene and 0.1% of patients reacted to caryophyllene oxide. Caryophyllene oxide gave positive reactions in only 2 out of 8 patients also reacting to the mixture of oxidized caryophyllene.
- Executive summary:
Consecutive dermatitis patients (n = 1511) in 6 European dermatology centres were patch tested with 3.0% oxidation mixture of caryophyllene (containing 25% β-caryophyllene and 35% caryophyllene oxide) or 3.9% caryophyllene oxide in non-stabilised white petrolatum (2005). About 0.5% of the patients reacted to oxidized caryophyllene and 0.1% of patients reacted to caryophyllene oxide. Caryophyllene oxide gave positive reactions in only 2 out of 8 patients also reacting to the mixture of oxidized caryophyllene. This study is reliable with restrictions (Klimisch 2) as it is a large clinical study reported in a peer-reviewed journal and meets generally accepted scientific principles.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.